Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment. | Int J Mol Sci | 2023 | 36982789 | PubTator, text mining | PubMed |
| Mycobacterial Heat Shock Proteins in Sarcoidosis and Tuberculosis. | Int J Mol Sci | 2023 | 36982159 | PubTator, text mining | PubMed |
| HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments. | Cancers (Basel) | 2023 | 36980624 | PubTator, text mining | PubMed |
| Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers. | Curr Oncol | 2023 | 36975409 | PubTator, text mining | PubMed |
| Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine. | Antibodies (Basel) | 2023 | 36975367 | PubTator, text mining | PubMed |
| Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. | J Clin Oncol | 2023 | 36972491 | PubTator, text mining | PubMed |
| Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus. | Front Immunol | 2023 | 36969253 | PubTator, text mining | PubMed |
| Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy. | Front Immunol | 2023 | 36969169 | PubTator, text mining | PubMed |
| Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates. | mBio | 2023 | 36946726 | PubTator, text mining | PubMed |
| Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein. | Proc Natl Acad Sci U S A | 2023 | 36943883 | PubTator, text mining | PubMed |
| DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score. | Clin Transl Radiat Oncol | 2023 | 36935856 | PubTator, text mining | PubMed |
| FCGR2A as one novel potential target for poor survival prognosis of clear cell renal cell carcinoma. | Medicine (Baltimore) | 2023 | 36930102 | PubTator, text mining | PubMed |
| CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study. | J Neuroimmune Pharmacol | 2023 | 36929282 | PubTator, text mining | PubMed |
| Tissue-specific macrophages: how they develop and choreograph tissue biology. | Nat Rev Immunol | 2023 | 36922638 | PubTator, text mining | PubMed |
| Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination. | Cell Rep Med | 2023 | 36921600 | PubTator, text mining | PubMed |
| Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses. | Mol Ther Oncolytics | 2023 | 36911070 | PubTator, text mining | PubMed |
| Polymorphisms in the FCER2 gene have associations with asthma and chronic obstructive pulmonary disease. | J Thorac Dis | 2023 | 36910110 | PubTator, text mining | PubMed |
| Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes. | Diabetologia | 2023 | 36907892 | PubTator, text mining | PubMed |
| Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia. | Int J Mol Sci | 2023 | 36901864 | PubTator, text mining | PubMed |
| Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events. | Cancers (Basel) | 2023 | 36900420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=27